In February, Congress finally took action to rein in PBMs via the Consolidated Appropriations Act of 2026. It included reforms like the delinking of PBM compensation from the price of a drug in ...

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...

Many healthcare AI startups are changing the way they charge for their technology, moving away from flat subscription rates and toward pricing linked to the financial impact of their tools. Investors ...

CMS’ new ACCESS model, slated to begin on July 1, aims to shift traditional Medicare fee-for-service toward value-based care by tying payments to patient outcomes and encouraging tech-enabled, ...

Parachute Health has raised a Series B round on the heels of another fundraise earlier this year for a total of $15 million. Insight Venture Partners became the latest investors to back the business ...